Efficacy [qlco]
Safety [hcpp]
cilostazol [orch, phsu]
Critical [qlco]
Literature [inpr]
cilostazol [orch, phsu]
Unique [qlco]
Antiplatelet agent [phsu]
Available [ftcn]
Over [spco]
Decade [qnco]
Phosphodiesterase III Inhibitor [moft]
arrested [dsyn]
Platelet aggregation [celf]
possess [mobd]
properties [qlco]
Study [mnob]
Variety [cnce]
State [geoa]
Including [ftcn]
peripheral arterial disease [dsyn]
Cerebrovascular disease [patf]
coronary artery disease [dsyn]
Percutaneous Coronary Intervention [topp]
cilostazol [orch, phsu]
APPEAR [qlco]
promise [idcn]
Agent [chvf]
Management [ocac]
State [geoa]
Bleeding [patf]
Profile [lbpr]
placebo [topp]
Combined [qlco]
Antiplatelet Agents [phsu]
cilostazol [orch, phsu]
APPEAR [qlco]
Bleeding [patf]
Benefit [qnco]
cilostazol [orch, phsu]
Limited [ftcn]
TOLERABILITY [resa]
Patients [podg]
Often [tmco]
Report [inpr]
Drug [phsu]
Discontinuation [hlca]
Headache [sosy]
Diarrhea [sosy]
Dizziness [sosy]
Increased heart rate [fndg]
Date [tmco]
Study [mnob]
Asian [popg]
Make [ftcn]
Difficult [qlco]
Diverse [qlco]
Paper [mnob]
Evolving [ftcn]
cilostazol [orch, phsu]
treatment [ftcn]
Vascular Diseases [dsyn]
